Oncology Biosimilars Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

May 2020| FMR834A| Fact Market Research

Report Highlights

Global Oncology Biosimilars Market- Scope of the Report

The recent study by Fact.MR on the global oncology biosimilars market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends currently determining the growth of the market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders and emerging players associated with the production of oncology biosimilars products. The study also provides dynamics responsible for influencing the future status of the global oncology biosimilars market over the forecast period.

A detailed assessment of the global oncology biosimilars market’s value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global oncology biosimilars market along with their product portfolio enhances the reliability of this comprehensive research study.

Global Oncology Biosimilars Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in the global oncology biosimilars market across the globe.

A comprehensive estimate on the global oncology biosimilars market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of global oncology biosimilars market during the forecast period.

This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.

Global Oncology Biosimilars Market: Analysis on Market Size Evaluation

The global oncology biosimilars market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for global oncology biosimilars market is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent global oncology biosimilars market segments, along with market attractiveness evaluation has been incorporated in the report.

Global Oncology Biosimilars Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the global oncology biosimilars report, which have helped deliver projections on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of the global oncology biosimilars market during the forecast period.

Country-specific valuation on demand for global oncology biosimilars has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

Global Oncology Biosimilars Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of global oncology biosimilars products along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of global oncology biosimilars products, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, such as product portfolio, key strategies along with an all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the global oncology biosimilars market. Prominent manufacturers with established market presence in the global oncology biosimilars market are Celltrion, Inc., Dr. Reddy’s Laboratories Ltd., Biocon, Teva Pharmaceutical Industries Ltd., and Sandoz International GmBh.

  • Table 1 : Global Biosimilars Market Snapshot
  • Table 2 : Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Drug Class, 2020-2025
  • Table 3 : Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2025
  • Table 4 : Global Oncology Biosimilars Market Size (US$ Mn) Forecast, Blood Cancer, 2020-2025
  • Table 5 : Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Leukemia, 2020-2025
  • Table 6 : Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2025
  • Table 7 : Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Region, 2020-2025
  • Table 8 : Approved Oncology Biosimilars by USFDA in new biosimilars pathway established under BPCIA Act
  • Table 9 : North America Oncology Biosimilars: Pipeline Overview, 2017-2020
  • Table 10 : North America Oncology Biosimilars Market Size (US$ Mn) Forecast, by Country, 2020-2025
  • Table 11 : North America Oncology Biosimilars Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2025
  • Table 12 : Europe Oncology Biosimilars Market Size (US$ Mn) Forecast, by Country, 2020-2025
  • Table 13 : Europe Oncology Biosimilars Market Size (US$ Mn) Forecast, by Drug Class, 2020-2025
  • Table 14 : Europe Oncology Biosimilars Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2025
  • Table 15 : Europe Oncology Biosimilars Market Size (US$ Mn) Forecast, by Blood Cancer, 2020-2025
  • Table 16 : Europe Oncology Biosimilars Market Size (US$ Mn) Forecast, by Leukemia, 2020-2025
  • Table 17 : Europe Oncology Biosimilars Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2025
  • Table 18 : Asia Pacific Oncology Biosimilars Market Size (US$ Mn) Forecast, by Country, 2020-2025
  • Table 19 : Asia Pacific Oncology Biosimilars Market Size (US$ Mn) Forecast, by Drug Class, 2020-2025
  • Table 20 : Asia Pacific Oncology Biosimilars Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2025
  • Table 21 : Asia Pacific Oncology Biosimilars Market Size (US$ Mn) Forecast, by Blood Cancer, 2020-2025
  • Table 22 : Asia Pacific Oncology Biosimilars Market Size (US$ Mn) Forecast, by Leukemia, 2020-2025
  • Table 23 : Asia Pacific Oncology Biosimilars Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2025
  • Table 24 : Rest of the World Oncology Biosimilars Market Size (US$ Mn) Forecast, by Country, 2020-2025
  • Table 25 : Rest of the World Oncology Biosimilars Market Size (US$ Mn) Forecast, Drug Class, 2020-2025
  • Table 26 : Rest of the World Oncology Biosimilars Market Size (US$ Mn) Forecast, by Disease Indication, 2020-2025
  • Table 27 : Rest of the World Oncology Biosimilars Market Size (US$ Mn) Forecast, by Blood Cancer, 2020-2025
  • Table 28 : Rest of the World Oncology Biosimilars Market Size (US$ Mn) Forecast, by Leukemia, 2020-2025
  • Table 29 : Rest of the World Oncology Biosimilars Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2025
  • Figure 1 : Global Oncology Biosimilars Market Size (US$ Mn) Forecast, 2020-2025
  • Figure 2 : Global Oncology Biosimilars Market Value Share, by Drug Class (2018)
  • Figure 3 : Global Oncology Biosimilars Market Value Share, by Disease Indication (2018)
  • Figure 4 : Global Oncology Biosimilars Market Value Share, by Distribution Channel (2018)
  • Figure 5 : Global Oncology Biosimilars Market Value Share, by Region (2018)
  • Figure 6 : U.S. Prevalence Share (%), By Cancer Type, 2015
  • Figure 7 : Global Estimation of Cancer, By New Cases & Deaths, 2017
  • Figure 8 : Global Oncology Biosimilars Market Value Share, by Drug Class, 2020 and 2025
  • Figure 9 : Global Oncology Biosimilars Market Attractiveness, by Drug Class, 2020-2025
  • Figure 10 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Monoclonal Antibody, 2020-2025
  • Figure 11 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hematopoietic Agents, 2020-2025
  • Figure 12 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by G-CSF, 2020-2025
  • Figure 13 : Global Oncology Biosimilars Market Value Share, by Disease Indication, 2020 and 2025
  • Figure 14 : Global Oncology Biosimilars Market Attractiveness, by Disease Indication, 2020-2025
  • Figure 15 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Breast Cancer, 2020-2025
  • Figure 16 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Non-small Cell Lung Cancer, 2020-2025
  • Figure 17 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Blood Cancer, 2020-2025
  • Figure 18 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Colorectal Cancer, 2020-2025
  • Figure 19 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Neutropenia, 2020-2025
  • Figure 20 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2020-2025
  • Figure 21 : Global Oncology Biosimilars Market Value Share, by Distribution Channel, 2020 and 2025
  • Figure 22 : Global Oncology Biosimilars Market Attractiveness, by Distribution Channel, 2020-2025
  • Figure 23 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacy,2020-2025
  • Figure 24 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacy,2020-2025
  • Figure 25 : Global Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 2020-2025
  • Figure 26 : Global Oncology Biosimilars Market Value Share, by Region, 2020 and 2025
  • Figure 27 : Global Oncology Biosimilars Market Attractiveness, by Region, 2020-2025
  • Figure 28 : North America Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2020-2025
  • Figure 29 : North America Oncology Biosimilars Market Value Share, by Country, 2020 and 2025
  • Figure 30 : North America Oncology Biosimilars Market Attractiveness, by Country, 2020-2025
  • Figure 31 : North America Oncology Biosimilars Market Value Share, by Distribution Channel, 2020 and 2025
  • Figure 32 : North America Oncology Biosimilars Market Attractiveness, by Distribution Channel, 2020-2025
  • Figure 33 : Europe Oncology Biosimilars Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2020-2025
  • Figure 34 : Europe Oncology Biosimilars Market Value Share, by Country, 2020 and 2025
  • Figure 35 : Europe Oncology Biosimilars Market Attractiveness, by Country, 2020-2025
  • Figure 36 : Europe Oncology Biosimilars Market Value Share, by Drug Class, 2020 and 2025
  • Figure 37 : Europe Oncology Biosimilars Market Attractiveness, by Drug Class, 2020-2025
  • Figure 38 : Europe Oncology Biosimilars Market Value Share, by Disease Indication, 2020 and 2025
  • Figure 39 : Europe Oncology Biosimilars Market Attractiveness, by Disease Indication, 2020-2025
  • Figure 40 : Europe Oncology Biosimilars Market Value Share, by Distribution Channel, 2020 and 2025
  • Figure 41 : Europe Oncology Biosimilars Market Attractiveness, by Distribution Channel, 2020-2025
  • Figure 42 : Asia Pacific Oncology Biosimilars Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2025
  • Figure 43 : Asia Pacific Oncology Biosimilars Market Value Share, by Country, 2020 and 2025
  • Figure 44 : Asia Pacific Oncology Biosimilars, Market Attractiveness, by Country, 2020-2025
  • Figure 45 : Asia Pacific Oncology Biosimilars Market Value Share, by Drug Class, 2020 and 2025
  • Figure 46 : Asia Pacific Oncology Biosimilars Market Attractiveness, by Drug Class, 2020-2025
  • Figure 47 : Asia Pacific Oncology Biosimilars Market Value Share, by Disease Indication, 2020 and 2025
  • Figure 48 : Asia Pacific Oncology Biosimilars Market Attractiveness, by Disease Indication, 2020-2025
  • Figure 49 : Asia Pacific Oncology Biosimilars Market Value Share, by Distribution Channel, 2020 and 2025
  • Figure 50 : Asia Pacific Oncology Biosimilars Market Attractiveness, by Distribution Channel, 2020-2025
  • Figure 51 : Rest of the World Oncology Biosimilars, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2025
  • Figure 52 : Rest of the World Oncology Biosimilars Market Value Share, by Country, 2020 and 2025
  • Figure 53 : Rest of the World Oncology Biosimilars, Market Attractiveness, by Country, 2020-2025
  • Figure 54 : Rest of the World Oncology Biosimilars Market Value Share, by Drug Class, 2020 and 2025
  • Figure 55 : Rest of the World Oncology Biosimilars Market Attractiveness, by Drug Class, 2020-2025
  • Figure 56 : Rest of the World Oncology Biosimilars Market Value Share, by Disease Indication, 2020 and 2025
  • Figure 57 : Rest of the World Oncology Biosimilars Market Attractiveness, by Disease Indication, 2020-2025
  • Figure 58 : Rest of the World Oncology Biosimilars Market Value Share, by Distribution Channel, 2020 and 2025
  • Figure 59 : Rest of the World Oncology Biosimilars Market Attractiveness, by Distribution Channel, 2020-2025
  • Figure 60 : Global Oncology Biosimilars Market Share, by Company, 2018
  • Figure 61 : Breakdown of Net Sales of Sandoz International GmbH (A Novartis Division), by Franchise, 2018 (%)
  • Figure 62 : Revenue (US$ Bn) & Y-o-Y Growth (%) of Sandoz International GmbH (A Novartis Division), 2013-2018
  • Figure 63 : Breakdown of Net Sales of Pfizer, Inc., by Region, 2018 (%)
  • Figure 64 : Revenue (US$ Bn) & Y-o-Y Growth (%) of Pfizer, Inc., 2013-2018
  • Figure 65 : Breakdown of Net Sales of Celltrion Inc., by Business Segments, 2018
  • Figure 66 : Revenue (US$ Mn) & Y-o-Y Growth (%) of Celltrion Inc., 2013-2018
  • Figure 67 : Breakdown of Net Sales of Dr. Reddy’s Laboratories Ltd., by Business Segments, 2018 (%)
  • Figure 68 : Revenue (US$ Bn) & Y-o-Y Growth (%) of Dr. Reddy’s Laboratories Ltd., 2013-2018
  • Figure 69 : Breakdown of Net Sales of Biocon, by Business Segments, 2018 (%)
  • Figure 70 : Revenue (US$ Mn) & Y-o-Y Growth (%) of Biocon, 2013-2018
  • Figure 71 : Breakdown of Net Sales of Teva Pharmaceutical Industries Ltd., by Business Segments, 2018 (%)
  • Figure 72 : Revenue (US$ Bn) & Y-o-Y Growth (%) of Teva Pharmaceutical Industries Ltd., 2013-2018
  • Figure 73 : Breakdown of Net Sales of STADA Arzneimittel AG, by Business Segments, 2018 (%)
  • Figure 74 : Revenue (US$ Bn) & Y-o-Y Growth (%) of STADA Arzneimittel AG, 2013-2018
  • Figure 75 : Revenue (US$ Mn) & Y-o-Y Growth (%) of Intas Pharmaceuticals Ltd., 2013-2018

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report